This is an accordion element with a series of buttons that open and close related content panels.
December 2022 - Kaitlyn Kelly
Dr. Kelly’s primary clinical practice includes the treatment of upper gastrointestinal malignancies, including gastric, pancreatic, and hepatobiliary cancers, as well as peritoneal surface malignancy, melanoma, and sarcoma. She is particularly interested in developing minimally invasive techniques for cancer surgery. Dr. Kelly’s primary clinical and research interest is gastric cancer. She is among the highest-volume gastric cancer surgeons in the country with over 10 year of experience, and has pioneered minimally-invasive surgical techniques for gastrectomy with comprehensive lymph node removal. Dr. Kelly also performs some operations with an open technique when necessary, and can perform additional procedures to treat liver cysts, chronic pancreatitis, and gallbladder disease. Dr. Kelly is board-certified in Complex General Surgical Oncology and General Surgery.
November 2022 - Qiongshi Lu
Dr. Lu received his Bachelor’s at Tsinghua University (Mathematics, 2012) and Ph.D. at Yale University (Biostatistics, 2017). He is currently an Assistant Professor in the Department of Biostatistics and Medical Informatics at UW-Madison. The Lu Lab develops and employs statistical methods to identify and interpret genetic associations for human complex traits. In particular, areas of expertise in the Lu Lab include genome-wide association study, non-coding genome annotation, genetic correlation estimation, polygenic risk prediction, and gene-environment interaction.
September 2022 - Jessica Lang
Jessica obtained her bachelors (Genetics, 2009) and doctorate (Cancer Biology, 2014) at the University of Wisconsin-Madison. She then completed two postdoctoral fellowships at Arizona State University and The Translational Genomics Research Institute (TGen). Jessica was awarded an NCI K99/R00 in 2019 to focus her studies on the role of super-enhancers in high-grade serous ovarian carcinomas. She joined the University of Wisconsin-Madison faculty in 2021, where she will leverage her experience in translational biology, genomics, and epigenetics.
The Lang Lab employs genomics technologies and translational models to determine the role of somatic mutation to epigenetic modifiers in the development and therapeutic vulnerabilities of ovarian cancers.